Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

972
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
972
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

12.5K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
12.5K
Cancer Vaccines01:30

Cancer Vaccines

340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

316
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
316
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Throughput Benchmarking and Throughput Variance Analysis to Evaluate the Efficiency of an Outpatient Endoscopy Unit.

Journal of medical systems·2026
Same author

Postpartum nonsteroidal anti-inflammatory drug exposure does not increase risk for flare in patients with inflammatory bowel disease.

Annals of gastroenterology·2026
Same author

Design and implementation of an end-to-end AI-driven colonoscopy recall workflow at scale.

JAMIA open·2026
Same author

GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo.

Annals of internal medicine·2026
Same author

Prospective Validation of the First US FDA-Approved Computer-Aided Quality Assessment Tool for Colonoscopy: An Initial Clinical Experience.

The American journal of gastroenterology·2025
Same author

Clinical management of inflammatory bowel disease from preconception to postpartum.

Expert review of gastroenterology & hepatology·2025

Related Experiment Video

Updated: Jun 7, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K

Colon cancer screening programs prevent cancer.

Duncan J Flynn1, Joseph D Feuerstein2

  • 1Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States.

World Journal of Gastroenterology
|November 20, 2024
PubMed
Summary
This summary is machine-generated.

Screening for colon cancer aids early diagnosis, reducing advanced cancer risks. Early detection through methods like fecal occult blood testing is more effective than waiting for symptom development.

Keywords:
Colon cancerColonoscopyPreventionQualityScreening

More Related Videos

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

6.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

218

Related Experiment Videos

Last Updated: Jun 7, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

6.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

218

Area of Science:

  • Gastroenterology
  • Oncology
  • Preventive Medicine

Background:

  • Colorectal cancer screening is crucial for early detection.
  • Patients presenting with symptoms often have left-sided lesions.
  • Current screening strategies vary in effectiveness.

Purpose of the Study:

  • To evaluate the effectiveness of colorectal cancer screening methods.
  • To compare early diagnosis rates between screening and symptomatic groups.
  • To analyze lesion location and associated symptoms in colorectal cancer patients.

Main Methods:

  • Review of screening protocols, including immunochemical fecal occult blood testing and colonoscopy.
  • Comparison of diagnostic outcomes between patients undergoing screening and those presenting with symptoms.
  • Analysis of lesion characteristics based on presentation method.

Main Results:

  • Screening for colon cancer significantly increases the likelihood of early diagnosis.
  • Patients with symptoms were more likely to have left-sided lesions.
  • Immunochemical fecal occult blood testing was the primary initial screening method for most patients.

Conclusions:

  • Early screening for colon cancer demonstrably reduces the risk of cancer diagnosis.
  • Screening leads to earlier detection and potentially less advanced cancer diagnoses compared to symptomatic presentation.
  • Further research is needed to clarify optimal timing for initial screening colonoscopies.